A US Food and Drug Administration advisory committee voted Wednesday that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed to remain on the market after a larger study failed to show that it was effective.
#people #opportunity #united-states #conversation #uncertainty #investigations #instruments #black-women #south-florida #blood-clots
[
add
]
[
|
|
...
]